A recent study on a prescription-strength version of fish oil is raising some questions and concerns about its true benefits.
Vascepa® was approved three years ago after a study showed it could reduce triglyceride levels and even reduce the risk of cardiac complications.
But now a conflicting study has been published by the Cleveland Clinic in Ohio.
This most recent study showed the opposite results.
Even though the original study was very promising, this most recent study did not confirm the original findings.
We need continued research to make sure of the benefits.

For more information on Vascepa®, visit our website www.leonardpiankomd.com and follow us on Facebook and LinkedIn.

And don't forget to LIKE, COMMENT, and SHARE this video.

#fishoil #vascepa #cardiology

свернуть